The use of 5-HT2 antagonists in drug development is often associated with the treatment of various psychiatric and neurological disorders, including depression, anxiety, schizophrenia, and hallucinogen-related disorders. Selective antagonists can help regulate serotonin signaling in a targeted manner, potentially leading to new treatment options.
If you need to purchase chemical raw materials, submit your demand information to get the latest quotations.
2-<3-(4-phenyl-1,2,3,6-tetrahydropyridyl)propyl>-2H-naphth<1,8-cd>isothiazole 1,1-dioxide
(2S,4R)-1-((S)-2-(tert-butyl)-4-oxo-7,10,13-trioxa-3-azahexadec-15-yn-1-oyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide
Acetonitrile, [[(1S)-2-hydroxy-1-methylethyl](phenylmethyl)amino]-
